“…3 Over the years, it has gained significance as a quick, safe and relatively simple method to differentiate malignant from benign thyroid nodules. It is also minimally invasive; 4 cost effective; 5 and, at the same time, highly reliable, with an accuracy rate as high as 97%; 3 thus, it is regarded as the gold-standard first-line diagnostic test in the evaluation of thyroid nodules. 6 The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC) was proposed in 2007 and classifies results into 6 diagnostic categories, each with a suggested risk of malignancy and specific recommendations for subsequent management.…”